相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Wenxing Gu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy
Kinan Alhallak et al.
LEUKEMIA (2021)
Nanomaterials for Protein Delivery in Anticancer Applications
Anne Yau et al.
PHARMACEUTICS (2021)
Nanomedicines: Redefining traditional medicine
Weijia Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia
Eben I. Lichtman et al.
CLINICAL CANCER RESEARCH (2021)
Recent advances in cellular therapy for malignant lymphoma
Junji Tanaka
CYTOTHERAPY (2021)
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
Raquel Lopes et al.
CANCERS (2021)
Analysis of Amount, Size, Protein Phenotype and Molecular Content of Circulating Extracellular Vesicles Identifies New Biomarkers in Multiple Myeloma
Ilaria Laurenzana et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Neurological complications of cancer immunotherapy (CAR T cells)
Daniel B. Rubin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)
Neurological complications of cancer immunotherapy
Patrick Roth et al.
CANCER TREATMENT REVIEWS (2021)
Influence of Purification Process on the Function of Synthetic Polymer Nanoparticles
Go Yasuno et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2021)
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Muyue Yang et al.
BIOACTIVE MATERIALS (2021)
An overview of multiplexed analyses of CAR T-cell therapies: insights and potential
Brittany Paige DePriest et al.
EXPERT REVIEW OF PROTEOMICS (2021)
BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications
Jooeun Bae et al.
LEUKEMIA (2020)
Chimeric antigen receptor T cells for treatment of transformed Waldenstrom macroglobulinemia
Rajat Bansal et al.
LEUKEMIA & LYMPHOMA (2020)
Graphene Oxide-Grafted Magnetic Nanorings Mediated Magnetothermodynamic Therapy Favoring Reactive Oxygen Species-Rebated immune Response for Enhanced Antitumor Efficacy
Xiaoli Liu et al.
ACS NANO (2020)
DNA-Based Delivery of Checkpoint Inhibitors in Muscle and Tumor Enables Long-Term Responses with Distinct Exposure
Lies Jacobs et al.
MOLECULAR THERAPY (2020)
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d,l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy
Tae In Wi et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2020)
Oxidative Stress and Photodynamic Therapy of Skin Cancers: Mechanisms, Challenges and Promising Developments
Alessandro Allegra et al.
ANTIOXIDANTS (2020)
Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies
A. Allegra et al.
ONCOLOGY REPORTS (2020)
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Frederik Soetaert et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Heme Oxygenase 1-Targeted Hybrid Nanoparticle for Chemo- and Immuno-Combination Therapy in Acute Myelogenous Leukemia
Seok-Beom Yong et al.
ADVANCED SCIENCE (2020)
A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity
Xia Li et al.
NATURE COMMUNICATIONS (2020)
Immune checkpoint inhibitors in multiple myeloma: A review of the literature
Santino Caserta et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
Vanessa Innao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials
Xinrong Xiang et al.
FRONTIERS IN PHARMACOLOGY (2020)
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Houli Zhao et al.
FRONTIERS OF MEDICINE (2020)
Studies of nanoparticle delivery with in vitro bio-engineered microtissues
Mingze Sun et al.
BIOACTIVE MATERIALS (2020)
AIM Platform: A Novel Nano Artificial Antigen-Presenting Cell-Based Clinical System Designed to Consistently Produce Multi-Antigen-Specific T-Cell Products with Potent and Durable Anti-Tumor Properties
Lauren Suarez et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2020)
Modular design of Bi-specific nanoplatform engaged in malignant lymphoma immunotherapy
Chen Bai et al.
NANOSCALE (2020)
Nanomedicine - a promising therapy for hematological malignancies
Lifen Huang et al.
BIOMATERIALS SCIENCE (2020)
Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy
Jooeun Bae et al.
LEUKEMIA (2019)
Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy
Qiujun Qiu et al.
ACTA BIOMATERIALIA (2019)
Poly (lactic-co-glycolic acid) nanospheres allow for high L-asparaginase encapsulation yield and activity
Anna Emmanuela Medeiros de Brito et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Iron Nanoparticles for Low-Power Local Magnetic Hyperthermia in Combination with Immune Checkpoint Blockade for Systemic Antitumor Therapy
Yu Chao et al.
NANO LETTERS (2019)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Multifunctional hyaluronate - nanoparticle hybrid systems for diagnostic, therapeutic and theranostic applications
Hyemin Kim et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin
Sung-Ju Lee et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy
Xia Dong et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia
Andra-Sorina Tatar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
Jiahao Chen et al.
NATURE MEDICINE (2019)
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Naval Daver et al.
CANCER DISCOVERY (2019)
The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective
Yongjiang Li et al.
NANOSCALE (2019)
Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
Sagun Goyal et al.
LEUKEMIA & LYMPHOMA (2018)
Magnesium-Stabilized Multifunctional DNA Nanoparticles for Tumor-Targeted and pH-Responsive Drug Delivery
Haoran Zhao et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications
Hyemin Kim et al.
ADVANCED MATERIALS (2018)
Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy
Ling-xiao Zhang et al.
BIOMATERIALS (2018)
Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics
Marta Overchuk et al.
BIOMATERIALS (2018)
Nanoparticles for dendritic cell-based immunotherapy
Tuan Hiep Tran et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Nanoparticles designed to regulate tumor microenvironment for cancer therapy
Min Li et al.
LIFE SCIENCES (2018)
Photosensitizer-Encapsulated Ferritins Mediate Photodynamic Therapy against Cancer-Associated Fibroblasts and Improve Tumor Accumulation of Nanoparticles
Lu Li et al.
MOLECULAR PHARMACEUTICS (2018)
Iron Oxide Nanoparticles-Based Vaccine Delivery for Cancer Treatment
Yi Zhao et al.
MOLECULAR PHARMACEUTICS (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
A facile approach to enhance antigen response for personalized cancer vaccination
Aileen Weiwei Li et al.
NATURE MATERIALS (2018)
Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy
Chih-Sheng Chiang et al.
NATURE NANOTECHNOLOGY (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma
Roberta Ettari et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics
Qin Chen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Immune oncology, immune responsiveness and the theory of everything
Tolga Turan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Structural DNA Nanotechnology: Artificial Nanostructures for Biomedical Research
Yonggang Ke et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 20 (2018)
Personalized Cancer Immunotherapy via Transporting Endogenous Tumor Antigens to Lymph Nodes Mediated by Nano Fe3O4
Binghua Wang et al.
SMALL (2018)
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Stephanie Vairy et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Aptamer-displaying peptide amphiphile micelles as a cell-targeted delivery vehicle of peptide cargoes
Josiah D. Smith et al.
PHYSICAL BIOLOGY (2018)
Immature myeloid-derived suppressor cells; A bridge between inflammation and cancer
Caterina Musolino et al.
ONCOLOGY REPORTS (2017)
Dendritic cell-based immunotherapy: a basic review and recent advances
Joao Constantino et al.
IMMUNOLOGIC RESEARCH (2017)
Identification and imaging of leukemia cells using dual-aptamer-functionalized graphene oxide complex
Amirhossein Bahreyni et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2017)
Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?
Mukundan Baskar Mannargudi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Tyrel T. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Lymphoma Immunochemotherapy: Targeted Delivery of Doxorubicin via a Dual Functional Nanocarrier
Qianyu Zhai et al.
MOLECULAR PHARMACEUTICS (2017)
Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control
Zipeng Zhen et al.
NANO LETTERS (2017)
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Tyrel T. Smith et al.
NATURE NANOTECHNOLOGY (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Delivery technologies for genome editing
Hao Yin et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies
David J. Byun et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Eameema Muntimadugu et al.
PHARMACOLOGICAL RESEARCH (2017)
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Shu Yang et al.
PHARMACOLOGICAL RESEARCH (2017)
Nanoparticles improve economic mileage for CARs
Miles A. Miller
Science Translational Medicine (2017)
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines
Domenico Franco et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2017)
Magnetic Nanoparticle Assisted Self-assembly of Cell Penetrating Peptides-Oligonucleotides Complexes for Gene Delivery
Moataz Dowaidar et al.
SCIENTIFIC REPORTS (2017)
Insight into the interactions between nanoparticles and cells
Jingchao Li et al.
BIOMATERIALS SCIENCE (2017)
Rituxan nanoconjugation prolongs drug/cell interaction and enables simultaneous depletion and enhanced Raman detection of lymphoma cells
Qian Yao et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment
Soumaya Kouidhi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Alexander N. R. Weber et al.
FRONTIERS IN IMMUNOLOGY (2017)
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
Wouter Hendrickx et al.
ONCOIMMUNOLOGY (2017)
Cancer immune resistance: can theories converge?
Rongze Lu et al.
EMERGING TOPICS IN LIFE SCIENCES (2017)
The potential of multi-compound nanoparticles to bypass drug resistance in cancer
C. G. Da Silva et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
Chao Wang et al.
ADVANCED MATERIALS (2017)
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
T. Shekarian et al.
ANNALS OF ONCOLOGY (2017)
Antibody Conjugated, Raman Tagged Hollow Gold-Silver Nanospheres for Specific Targeting and Multimodal Dark-Field/SERS/Two Photon-FLIM Imaging of CD19(+) B Lymphoblasts
Timea Nagy-Simon et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Efficient Nanovaccine Delivery in Cancer Immunotherapy
Guizhi Zhu et al.
ACS NANO (2017)
Biodegradable Photonic Melanoidin for Theranostic Applications
Min-Young Lee et al.
ACS NANO (2016)
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells
Alessandro Allegra et al.
BLOOD CELLS MOLECULES AND DISEASES (2016)
Tolerance and immune suppression in the tumor microenvironment
Suzanne Ostrand-Rosenberg
CELLULAR IMMUNOLOGY (2016)
Anti-CD20 antibody treatment of non-Hodgkin lymphomas
Marianne Engelhard
CLINICAL IMMUNOLOGY (2016)
Nanomedicine approaches in acute lymphoblastic leukemia
Andra-Sorina Tatar et al.
JOURNAL OF CONTROLLED RELEASE (2016)
A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study
Mark H. Kirschbaum et al.
LEUKEMIA & LYMPHOMA (2016)
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T. Nghiem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures
Enza Fazio et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
Chunbai He et al.
NATURE COMMUNICATIONS (2016)
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
Hee Dong Han et al.
SCIENTIFIC REPORTS (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing
Wujin Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Rodney A. Rosalia et al.
BIOMATERIALS (2015)
Phage-AgNPs complex as SERS probe for U937 cell identification
Germana Lentini et al.
BIOSENSORS & BIOELECTRONICS (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas
D. Perez-Callejo et al.
CANCER TREATMENT REVIEWS (2015)
Gold Nanoparticles: Recent Advances in the Biomedical Applications
Xiaoying Zhang
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Effect of the surface modification, size, and shape on cellular uptake of nanoparticles
Sara Salatin et al.
CELL BIOLOGY INTERNATIONAL (2015)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
Vaccination of multiple myeloma: Current strategies and future prospects
Alessandro Allegra et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer
Sima Rahimian et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles
Noor Mohammad Danesh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Vaccination strategies in lymphoproliferative disorders: Failures and successes
A. Allegra et al.
LEUKEMIA RESEARCH (2015)
CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia
Vinu Krishnan et al.
MOLECULAR PHARMACEUTICS (2015)
CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia
Hong Li et al.
MOLECULAR PHARMACEUTICS (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Bispecific T-cell engagers for cancer immunotherapy
Amelia M. Huehls et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
Jaeyun Kim et al.
NATURE BIOTECHNOLOGY (2015)
Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo
Hiroko Toyota et al.
ONCOLOGY REPORTS (2015)
Particle Margination and Its Implications on Intravenous Anticancer Drug Delivery
Erik Carboni et al.
AAPS PHARMSCITECH (2014)
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Microfluidic generation of chitosan/CpG oligodeoxynucleotide nanoparticles with enhanced cellular uptake and immunostimulatory properties
Song Chen et al.
LAB ON A CHIP (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
Charles G. Drake et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Dendrimers: synthesis, applications, and properties
Elham Abbasi et al.
NANOSCALE RESEARCH LETTERS (2014)
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Kanika Madaan et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2014)
Aptamer-Conjugated Multifunctional Nanoflowers as a Platform for Targeting, Capture, and Detection in Laser Desorption Ionization Mass Spectrometry
Ismail Ocsoy et al.
ACS NANO (2013)
pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides
John T. Wilson et al.
ACS NANO (2013)
Carbon-Based Nanomaterials: Multifunctional Materials for Biomedical Engineering
Chaenyung Cha et al.
ACS NANO (2013)
Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
Uma Prabhakar et al.
CANCER RESEARCH (2013)
Regulatory Roles of the Tumor Necrosis Factor Receptor BCMA
Christine M. Coquery et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2013)
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma
Alessandro Allegra et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
Jerome Galon et al.
IMMUNITY (2013)
High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Susan O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pharmacokinetics and Pharmacodynamics of Vincristine Sulfate Liposome Injection (VSLI) in Adults With Acute Lymphoblastic Leukemia
Jeffrey A. Silverman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Thermo-plasmonics: using metallic nanostructures as nano-sources of heat
Guillaume Baffou et al.
LASER & PHOTONICS REVIEWS (2013)
Simultaneous inhibition of aberrant cancer kinome using rationally designed polymer-protein core-shell nanomedicine
Parwathy Chandran et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Correction: New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles
Nelly Mezzaroba et al.
PLoS One (2013)
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh et al.
NANOSCALE RESEARCH LETTERS (2013)
Human regulatory T cells induce T-lymphocyte senescence
Jian Ye et al.
BLOOD (2012)
Hydrogels for Protein Delivery
Tina Vermonden et al.
CHEMICAL REVIEWS (2012)
Targeting tumor antigens to dendritic cells using particulate carriers
Medha D. Joshi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Twan Lammers et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Nanoparticles in Oncology: The New Theragnostic Molecules
Alessandro Allegra et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
Brandon Kwong et al.
BIOMATERIALS (2011)
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors
Alessandro Allegra et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
TOXICOLOGY OF NANOMATERIALS USED IN NANOMEDICINE
Jinshun Zhao et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Weihsu C. Chen et al.
BLOOD (2010)
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Andrew L. Doedens et al.
CANCER RESEARCH (2010)
Efficacy, Biodistribution, and Pharmacokinetics of CD22-Targeted Pegylated Liposomal Doxorubicin in a B-cell Non-Hodgkin's Lymphoma Xenograft Mouse Model
Joseph M. Tuscano et al.
CLINICAL CANCER RESEARCH (2010)
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
Kristin Loomis et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Antibody-drug conjugates for cancer: poised to deliver?
Bethan Hughes
NATURE REVIEWS DRUG DISCOVERY (2010)
Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses
Ana Lucia Dominguez et al.
VACCINE (2010)
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
Nathalie A. Johnson et al.
BLOOD (2009)
Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
Matthieu Camus et al.
CANCER RESEARCH (2009)
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows
F. Gentile et al.
JOURNAL OF BIOMECHANICS (2008)
Nitric oxide, apoptosis and macrophage polarization during tumor progression
Andreas Weigert et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia
Ching-Hon Pui et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
ST Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Role of tumor-associated macrophages in tumor progression and invasion
Alberto Mantovani et al.
CANCER AND METASTASIS REVIEWS (2006)
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
N Dinauer et al.
BIOMATERIALS (2005)
Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma
K Tanaka et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2005)
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells
M Harata et al.
BLOOD (2004)
Small-scale systems for in vivo drug delivery
DA LaVan et al.
NATURE BIOTECHNOLOGY (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma
A Ito et al.
CANCER SCIENCE (2003)
Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles
A Ito et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells
M Nesbit et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
